Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared some top articles.
1. “Hot off the press!
Pleased to share our commentary in ASCO Journal of Clinical Oncology in the Comments and Controversies section ‘Precision Oncology and Modernizing Evidence Standards: A Critical Commentary on the Cochrane Review’.
Why traditional RCT-focused reviews may miss the mark in Precision Medicine era.
Time to evolve our evidence frameworks!”
Title: Precision Oncology and Modernizing Evidence Standards: A Critical Commentary on the Cochrane Review
Journal: JCO
Authors: Vivek Subbiah, Razelle Kurzrock
2. Title: Cancer treatment paradigms in the precision medicine era
Journal: Nature Medicine
Authors: Vivek Subbiah, Giuseppe Curigliano, Jason K. Sicklick, Shumei Kato, Kjetil Tasken, Arielle Medford, Damian T. Rieke, Hui-Zi Chen, Adam Wahida, Lars Buschhorn, Denis Horgan, Razelle Kurzrock
3. Title: Sucralose consumption ablates cancer immunotherapy response through microbiome disruption
Journal: Cancer Discovery
Authors: Kristin M. Morder, Madison Nguyen, Drew N. Wilfahrt, Zakaria Larbi. Dahmani, Ansen BP. Burr, Bingxian Xie, Michael Morikone, Hector Nieves-Rosado, William G. Gunn, Drew E. Hurd, Hong Wang, Steven J. Mullett, Kaitlin Bossong, Stacy L. Gelhaus, Dhivyaa Rajasundaram, Lawrence P. Kane, Greg M. Delgoffe, Jishnu Das, Diwakar Davar, and Abigail E. Overacre-Delgoffe
4. Title: World’s first AI-designed viruses a step towards AI-generated life
Journal: Nature
Authors: Katie Kavanagh
5.Title: Detection of Cancers Three Years prior to Diagnosis Using Plasma Cell-Free DNA
Journal: Cancer Discovery
Author: Yuxuan Wang, Corinne E. Joshu, Samuel D. Curtis, Christopher Douville, Vernon A. Burk, Meng Ru, Maria Popoli, Janine Ptak, Lisa Dobbyn, Natalie Silliman, Josef Coresh, Eric Boerwinkle, Anna Prizment, Chetan Bettegowda, Kenneth W. Kinzler, Nickolas Papadopoulos, Elizabeth A. Platz, and Bert Vogelstein
More from Vivek Subbiah on OncoDaily.